Related Experiment Video
Updated: Jul 10, 2026
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Hypocoagulability among people living with HIV at Hoima Regional Referral Hospital, Western Uganda: a cross-sectional
Abdisalam Ahmed Sandeyl1, Mohamed Jayte1, Farah Dubad Abdi1
1Department of Internal Medicine, Faculty of Clinical Medicine and Dentistry, Kampala International University, Ishaka - Bushenyi, Uganda.
Background:
Coagulation abnormalities are an under-recognized complication among people living with HIV. Despite widespread antiretroviral therapy (ART), hematologic dysfunction, including coagulation and platelet abnormalities, continues to contribute to morbidity in sub-Saharan Africa.
Objective:
This study aimed to determine the prevalence, associated factors, and clinical features of hypocoagulability among people with HIV at Hoima Regional Referral Hospital (HRRH).
Methods:
We conducted a cross-sectional study at HRRH, Western Uganda, from May to July 2025. Sociodemographic, clinical, and behavioral data were collected via questionnaires and chart review. Laboratory evaluation included platelet count, prothrombin time (PT), activated partial thromboplastin time (aPTT), and international normalized ratio (INR). Hypocoagulability was defined as ≥ 1 abnormal parameter: PT > 13.5 s, aPTT > 35 s, INR > 1.2, or platelet count <150,000/µL. Multivariable logistic regression identified independent factors associated with hypocoagulability.
Results:
The study enrolled 389 HIV-positive adults. Hypocoagulability was detected in 121 participants (31.1%). The most frequent abnormalities were prolonged PT (14.1%), elevated INR (11.8%), prolonged aPTT (11.1%), and thrombocytopenia (9.3%). Independent factors associated with hypocoagulability included older age (aOR: 2.012, 95% CI = 1.165-4.813), alcohol use (aOR: 2.177, 95% CI = 1.250-3.792), ART-naïve status (aOR: 3.159, 95% CI 1.057-9.364), and unsuppressed viral load (aOR: 2.235, 95% CI = 1.297-3.851). Clinically, affected participants more commonly reported easy bruising (33.1%), frequent nose bleeds (29.8%), and heavy menstrual bleeding among women (39.2%) compared to participants without hypocoagulability.
Conclusion:
These findings highlight the importance of early detection, promotion of ART adherence, targeted screening of high-risk groups, and integrated management strategies to reduce bleeding-related morbidity in HIV care.
Related Concept Videos
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins